How GLP-1 Manages Diabetes
In the pancreas, they enhance glucose-dependent insulin secretion while suppressing glucagon release, improving glycemic control
As mentioned, a secondary analysis of an RCT assessing the cardiometabolic effects of exenatide in 40 people with schizophrenia 140 also looked at measures of cognition and psychosocial functioning (that is, Brief Assessment of Cognition in Schizophrenia, ReyOsterreith Complex Figure Test, Short-Form Health Survey, Personal and Social Performance Scale, Positive and Negative Syndrome Scale), but found no effect for this GLP-1RA compared with placebo over 3 months 133
doi: 10.1111/dom.14110 152 WillmsBWernerJHolstJJOrskovCCreutzfeldtWNauckMA
Medications included in Noom GLP-1 Rx Program are produced in USP-compliant, state-regulated pharmacies but not reviewed by the FDA for safety, efficacy or quality